Compare GOSS & ORRF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GOSS | ORRF |
|---|---|---|
| Founded | 2015 | 1919 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 615.7M | 734.3M |
| IPO Year | 2018 | 1995 |
| Metric | GOSS | ORRF |
|---|---|---|
| Price | $0.50 | $35.33 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 1 |
| Target Price | $4.91 | ★ $42.00 |
| AVG Volume (30 Days) | ★ 27.3M | 140.7K |
| Earning Date | 01-01-0001 | 04-28-2026 |
| Dividend Yield | N/A | ★ 3.41% |
| EPS Growth | ★ 78.81 | N/A |
| EPS | N/A | ★ 3.07 |
| Revenue | ★ $114,701,000.00 | $27,312,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.49 |
| P/E Ratio | ★ N/A | $11.46 |
| Revenue Growth | N/A | ★ 40.21 |
| 52 Week Low | $0.33 | $25.57 |
| 52 Week High | $3.87 | $40.72 |
| Indicator | GOSS | ORRF |
|---|---|---|
| Relative Strength Index (RSI) | 23.06 | 40.01 |
| Support Level | $0.33 | $34.51 |
| Resistance Level | $1.23 | $35.28 |
| Average True Range (ATR) | 0.09 | 1.08 |
| MACD | -0.00 | -0.25 |
| Stochastic Oscillator | 8.98 | 26.99 |
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
Orrstown Financial Services Inc is a holding company engaged in commercial banking and trust business, this involves accepting demand, time, and savings deposits and granting loans. The company is also engaged in lending services for commercial, residential, commercial mortgages, construction, municipal, and various forms of consumer lending, and deposit services that include checking, savings, time, and money market deposits. It also provides investment and brokerage services through its Financial Advisors division. The Company earns fees from its deposit clients for transaction-based account maintenance and overdraft services, It also earns wealth management and investment brokerage fees from its contracts with trusts. The company operates in a segment, namely Community Banking.